BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15687104)

  • 21. Roles of angiopoietins in kidney development and disease.
    Woolf AS; Gnudi L; Long DA
    J Am Soc Nephrol; 2009 Feb; 20(2):239-44. PubMed ID: 18799719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization.
    Bogdanovic E; Nguyen VP; Dumont DJ
    J Cell Sci; 2006 Sep; 119(Pt 17):3551-60. PubMed ID: 16895971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiopoietin: a TIE(d) balance in tumor angiogenesis.
    Shim WS; Ho IA; Wong PE
    Mol Cancer Res; 2007 Jul; 5(7):655-65. PubMed ID: 17634421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
    Cao Y; Sonveaux P; Liu S; Zhao Y; Mi J; Clary BM; Li CY; Kontos CD; Dewhirst MW
    Cancer Res; 2007 Apr; 67(8):3835-44. PubMed ID: 17440098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An autocrine linkage between matrix metalloproteinase-14 and Tie-2 via ectodomain shedding modulates angiopoietin-1-dependent function in endothelial cells.
    Onimaru M; Yonemitsu Y; Suzuki H; Fujii T; Sueishi K
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):818-26. PubMed ID: 20056911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors.
    Papapetropoulos A; García-Cardeña G; Dengler TJ; Maisonpierre PC; Yancopoulos GD; Sessa WC
    Lab Invest; 1999 Feb; 79(2):213-23. PubMed ID: 10068209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
    Caine GJ; Stonelake PS; Lip GY; Blann AD
    Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-1 promotes neurite outgrowth from dorsal root ganglion cells positive for Tie-2 receptor.
    Kosacka J; Figiel M; Engele J; Hilbig H; Majewski M; Spanel-Borowski K
    Cell Tissue Res; 2005 Apr; 320(1):11-9. PubMed ID: 15714275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UV radiation induces the release of angiopoietin-2 from dermal microvascular endothelial cells.
    Navid F; Kolbe L; Stäb F; Korff T; Neufang G
    Exp Dermatol; 2012 Feb; 21(2):147-53. PubMed ID: 22142364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1.
    Simon MP; Tournaire R; Pouyssegur J
    J Cell Physiol; 2008 Dec; 217(3):809-18. PubMed ID: 18720385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiopoietins in angiogenesis.
    Fagiani E; Christofori G
    Cancer Lett; 2013 Jan; 328(1):18-26. PubMed ID: 22922303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells.
    Clarkin CE; Emery RJ; Pitsillides AA; Wheeler-Jones CP
    J Cell Physiol; 2008 Feb; 214(2):537-44. PubMed ID: 17685428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
    Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
    Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
    Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways.
    Maliba R; Lapointe S; Neagoe PE; Brkovic A; Sirois MG
    Cell Signal; 2006 Nov; 18(11):1947-57. PubMed ID: 16617006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.
    Riccioni R; Diverio D; Mariani G; Buffolino S; Riti V; Saulle E; Petrucci E; Cedrone M; Lo-Coco F; Foà R; Peschle C; Testa U
    Stem Cells; 2007 Aug; 25(8):1862-71. PubMed ID: 17446561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
    Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
    Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple roles of angiopoietins in atherogenesis.
    Ahmed A; Fujisawa T
    Curr Opin Lipidol; 2011 Oct; 22(5):380-5. PubMed ID: 21881497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking.
    Pfaff D; Fiedler U; Augustin HG
    J Leukoc Biol; 2006 Oct; 80(4):719-26. PubMed ID: 16864601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.